These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
2. A UK nationwide prospective study of treatment change in MODY: genetic subtype and clinical characteristics predict optimal glycaemic control after discontinuing insulin and metformin. Shepherd MH; Shields BM; Hudson M; Pearson ER; Hyde C; Ellard S; Hattersley AT; Patel KA; Diabetologia; 2018 Dec; 61(12):2520-2527. PubMed ID: 30229274 [TBL] [Abstract][Full Text] [Related]
3. Maturity onset diabetes of the young (MODY) in Chinese children: genes and clinical phenotypes. Ming-Qiang Z; Yang-Li D; Ke H; Wei W; Jun-Fen F; Chao-Chun Z; Guan-Ping D J Pediatr Endocrinol Metab; 2019 Jul; 32(7):759-765. PubMed ID: 31216263 [TBL] [Abstract][Full Text] [Related]
4. Mutations in the genes encoding the transcription factors hepatocyte nuclear factor 1 alpha (HNF1A) and 4 alpha (HNF4A) in maturity-onset diabetes of the young. Ellard S; Colclough K Hum Mutat; 2006 Sep; 27(9):854-69. PubMed ID: 16917892 [TBL] [Abstract][Full Text] [Related]
5. Maturity onset diabetes of the young: Seek and you will find. Heuvel-Borsboom H; de Valk HW; Losekoot M; Westerink J Neth J Med; 2016 Jun; 74(5):193-200. PubMed ID: 27323672 [TBL] [Abstract][Full Text] [Related]
7. Maturity onset diabetes of youth (MODY) in Turkish children: sequence analysis of 11 causative genes by next generation sequencing. Ağladıoğlu SY; Aycan Z; Çetinkaya S; Baş VN; Önder A; Peltek Kendirci HN; Doğan H; Ceylaner S J Pediatr Endocrinol Metab; 2016 Apr; 29(4):487-96. PubMed ID: 26669242 [TBL] [Abstract][Full Text] [Related]
8. Clinical and genetic characterization and long-term evaluation of individuals with maturity-onset diabetes of the young (MODY): The journey towards appropriate treatment. Campos Franco P; Santos de Santana L; Dantas Costa-Riquetto A; Santomauro Junior AC; Jorge AAL; Gurgel Teles M Diabetes Res Clin Pract; 2022 May; 187():109875. PubMed ID: 35472491 [TBL] [Abstract][Full Text] [Related]
9. Identification of HNF1A-MODY and HNF4A-MODY in Irish families: phenotypic characteristics and therapeutic implications. Kyithar MP; Bacon S; Pannu KK; Rizvi SR; Colclough K; Ellard S; Byrne MM Diabetes Metab; 2011 Dec; 37(6):512-9. PubMed ID: 21683639 [TBL] [Abstract][Full Text] [Related]
10. Maturity Onset Diabetes of the Young (MODY) in Tunisia: Low frequencies of GCK and HNF1A mutations. Ben Khelifa S; Martinez R; Dandana A; Khochtali I; Ferchichi S; Castaño L Gene; 2018 Apr; 651():44-48. PubMed ID: 29408271 [TBL] [Abstract][Full Text] [Related]
11. Targeted next-generation sequencing reveals MODY in up to 6.5% of antibody-negative diabetes cases listed in the Norwegian Childhood Diabetes Registry. Johansson BB; Irgens HU; Molnes J; Sztromwasser P; Aukrust I; Juliusson PB; Søvik O; Levy S; Skrivarhaug T; Joner G; Molven A; Johansson S; Njølstad PR Diabetologia; 2017 Apr; 60(4):625-635. PubMed ID: 27913849 [TBL] [Abstract][Full Text] [Related]
12. Diagnosis of hepatic nuclear factor 1A monogenic diabetes mellitus (HNF1A-MODY) impacts antihyperglycemic treatment. Schnedl WJ; Holasek SJ; Schenk M; Enko D; Mangge H Wien Klin Wochenschr; 2021 Mar; 133(5-6):241-244. PubMed ID: 33245425 [TBL] [Abstract][Full Text] [Related]
13. Co-inheritance of HNF1a and GCK mutations in a family with maturity-onset diabetes of the young (MODY): implications for genetic testing. López-Garrido MP; Herranz-Antolín S; Alija-Merillas MJ; Giralt P; Escribano J Clin Endocrinol (Oxf); 2013 Sep; 79(3):342-7. PubMed ID: 23009393 [TBL] [Abstract][Full Text] [Related]
14. Genetic and Clinical Characterization of Patients with Maturity-Onset of Diabetes of the Young (MODY): Identification of Novel Variations. Ateş EA; Üstay Ö; Polat H; Apaydın T; Elbasan O; Yıldırım Ö; Güney Aİ Balkan Med J; 2021 Sep; 38(5):272-277. PubMed ID: 34462253 [TBL] [Abstract][Full Text] [Related]
15. Successful maintenance on sulphonylurea therapy and low diabetes complication rates in a HNF1A-MODY cohort. Bacon S; Kyithar MP; Rizvi SR; Donnelly E; McCarthy A; Burke M; Colclough K; Ellard S; Byrne MM Diabet Med; 2016 Jul; 33(7):976-84. PubMed ID: 26479152 [TBL] [Abstract][Full Text] [Related]
16. Half-Life of Sulfonylureas in HNF1A and HNF4A Human MODY Patients is not Prolonged as Suggested by the Mouse Hnf1a(-/-) Model. Urbanova J; Andel M; Potockova J; Klima J; Macek J; Ptacek P; Mat'oska V; Kumstyrova T; Heneberg P Curr Pharm Des; 2015; 21(39):5736-48. PubMed ID: 26446475 [TBL] [Abstract][Full Text] [Related]
17. Clinical application of ACMG-AMP guidelines in HNF1A and GCK variants in a cohort of MODY families. Santana LS; Caetano LA; Costa-Riquetto AD; Quedas EPS; Nery M; Collett-Solberg P; Boguszewski MCS; Vendramini MF; Crisostomo LG; Floh FO; Zarabia ZI; Kohara SK; Guastapaglia L; Passone CGB; Sewaybricker LE; Jorge AAL; Teles MG Clin Genet; 2017 Oct; 92(4):388-396. PubMed ID: 28170077 [TBL] [Abstract][Full Text] [Related]
18. Maturity-onset diabetes of the young (MODY): an update. Anık A; Çatlı G; Abacı A; Böber E J Pediatr Endocrinol Metab; 2015 Mar; 28(3-4):251-63. PubMed ID: 25581748 [TBL] [Abstract][Full Text] [Related]
19. Digenic heterozygous HNF1A and HNF4A mutations in two siblings with childhood-onset diabetes. Shankar RK; Ellard S; Standiford D; Pihoker C; Gilliam LK; Hattersley A; Dolan LM Pediatr Diabetes; 2013 Nov; 14(7):535-8. PubMed ID: 23551881 [TBL] [Abstract][Full Text] [Related]
20. Molecular diagnosis of maturity-onset diabetes of the young (MODY) in Turkish children by using targeted next-generation sequencing. Anık A; Çatlı G; Abacı A; Sarı E; Yeşilkaya E; Korkmaz HA; Demir K; Altıncık A; Tuhan HÜ; Kızıldağ S; Özkan B; Ceylaner S; Böber E J Pediatr Endocrinol Metab; 2015 Nov; 28(11-12):1265-71. PubMed ID: 26226118 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]